Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-09-19
1999-09-28
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514406, 546152, 5483731, 5483751, C07D40106, A61K 31415
Patent
active
059589485
ABSTRACT:
The compounds of the formula wherein A, R.sub.1, R.sub.3, X.sub.1, Y and Z are as defined herein, have corticotropin-releasing factor (CRF) antagonist activity. They are useful in the treatment of illnesses induced by CRF, such as stress and anxiety related disorders.
REFERENCES:
patent: 4605642 (1986-08-01), Rivier et al.
patent: 5063248 (1991-11-01), Abren et al.
Bright Gene M.
Welch, Jr. Willard M.
Creagan B. Timothy
Davis Zinna Northington
Ginsburg Paul H.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Substituted pyrazoles as CRF antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrazoles as CRF antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrazoles as CRF antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-703709